UniProtKB/SwissProt variant VAR

Variant information

Variant position:

134

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Methionine (M) to Threonine (T) at position 134 (M134T, p.Met134Thr).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and hydrophobic (M) to medium size and polar (T)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In DEE72.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs1567841596 [ dbSNP | Ensembl ]

Sequence information

Variant position:

134

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

382

The length of the canonical sequence.

Location on the sequence:

ARLERSKLRRQKANARERNR M HDLNAALDNLRKVVPCYSKT

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ARLERSKLRRQKANARERNRMHDLNAALDNLRKVVPCYSKT

Mouse                         ARLERSKLRRQKANARERNRMHDLNAALDNLRKVVPCYSKT

Rat                           ARLERSKLRRQKANARERNRMHDLNAALDNLRKVVPCYSKT

Zebrafish                     ARLERSKVRRQKANARERTRMHDLNSALDNLLKVVPCYSKT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 382	Neurogenic differentiation factor 2
Domain	121 – 173	bHLH

Literature citations

De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy.
Sega A.G.; Mis E.K.; Lindstrom K.; Mercimek-Andrews S.; Ji W.; Cho M.T.; Juusola J.; Konstantino M.; Jeffries L.; Khokha M.K.; Lakhani S.A.;
J. Med. Genet. 56:113-122(2019)
Cited for: INVOLVEMENT IN DEE72; VARIANTS DEE72 GLN-130 AND THR-134;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q15784: Variant p.Met134Thr